Celldex EVP granted options for 115,000 shares
Celldex Therapeutics, Inc. Executive VP & Chief Scientific Officer Tibor Keler received an incentive stock option grant covering 115,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Celldex Therapeutics, Inc. Executive VP & Chief Scientific Officer Tibor Keler received an incentive stock option grant covering 115,000 shares of common stock. The option has an exercise price of $34.09 per share and expires on June 25, 2036.
According to the vesting terms, 25% of the option vests on June 25, 2027, with the remaining 75% vesting in equal quarterly installments over the following 12 quarters. After this grant, Keler holds options for 115,000 underlying shares directly.
Insider Trade Summary
Grant/Award: 115,000 shares
Grant/Award
1 txn
Insider
KELER TIBOR
Role
EXECUTIVE VP & CSO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Incentive Stock Option (right to buy) | 115,000 | $0.00 | $0.00 |
Holdings After Transaction:
Incentive Stock Option (right to buy) — 115,000 contracts (Direct)
Footnotes (2)
- F1. Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- F2. 25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Key Figures
Option grant size: 115,000 shares
Exercise price: $34.09 per share
Expiration date: June 25, 2036
+2 more
5 metrics
Option grant size
115,000 shares
Incentive stock option underlying common shares
Exercise price
$34.09 per share
Incentive stock option strike price
Expiration date
June 25, 2036
Option expiration
First vesting date
June 25, 2027
25% of option vests
Post-grant option holdings
115,000 options
Total options held following transaction
Key Terms
Incentive Stock Option, 2021 Omnibus Equity Incentive Plan, vesting, exercise price, +1 more
5 terms
Incentive Stock Option financial
"Incentive Stock Option (right to buy)"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
2021 Omnibus Equity Incentive Plan financial
"granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan"
vesting financial
"25% vest on June 25, 2027 and the remainder vest quarterly"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: "34.0900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-25T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Celldex (CLDX) disclose about Tibor Keler in this Form 4?
Celldex disclosed that Executive VP & CSO Tibor Keler received an incentive stock option to acquire 115,000 shares of common stock at $34.09 per share, expiring June 25, 2036, as part of equity compensation.
What is the exercise price of Tibor Keler’s Celldex (CLDX) stock options?
The exercise price of the incentive stock option is $34.09 per share. This is the fixed price at which Keler can purchase Celldex common stock once the option vests and is exercisable.
When do Tibor Keler’s newly granted Celldex (CLDX) options vest?
Twenty-five percent of the option vests on June 25, 2027. The remaining 75% vests in equal quarterly installments over the next 12 quarters, creating a multi-year vesting schedule linked to continued service.
When do Tibor Keler’s Celldex (CLDX) stock options expire?
The incentive stock option granted to Tibor Keler expires on June 25, 2036. After that expiration date, any unexercised portion of the option will no longer be available for him to exercise.
Under which plan were Tibor Keler’s Celldex (CLDX) options granted?
The option was granted under Celldex’s 2021 Omnibus Equity Incentive Plan. This plan provides a framework for issuing stock-based awards like options to executives and employees as part of their compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates